Adriana Ioachimescu
Overview
Explore the profile of Adriana Ioachimescu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
164
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cheok S, Tavakoli-Sabour S, Beck R, Zwagerman N, Ioachimescu A
J Neurooncol
. 2024 Nov;
171(1):1-9.
PMID: 39607571
Purpose: Acromegaly is characterized by an insidious clinical presentation and delayed diagnosis. Longer delays are associated with more comorbidities which can persist after treatment of the growth hormone-secreting pituitary adenoma...
2.
Medina E, Zohdy Y, Porto E, Revuelta Barbero J, Bray D, Maldonado J, et al.
Front Endocrinol (Lausanne)
. 2023 Aug;
14:1195792.
PMID: 37529607
Introduction: Aggressive prolactinomas (APRLs) pose a significant clinical challenge due to their high rate of regrowth and potentially life-threatening complications. In this study, we present a case of a patient...
3.
Greven A, Douglas J, Couceyro J, Nakirikanti A, Dawoud R, Revuelta-Barbero M, et al.
J Neurol Surg B Skull Base
. 2023 Feb;
84(1):1-7.
PMID: 36743713
The purpose of this study was to evaluate pituitary tumor patient satisfaction with telemedicine, patient preference for telemedicine, potential socioeconomic benefit of telemedicine, and patients' willingness to proceed with surgery...
4.
Wang A, Neill S, Newman S, Tryfonidou M, Ioachimescu A, Rossi M, et al.
BMC Endocr Disord
. 2021 Sep;
21(1):185.
PMID: 34517852
Background: Cushing's disease (CD) is defined as hypercortisolemia caused by adrenocorticotropic hormone (ACTH)-secreting pituitary adenomas (corticotroph PA) that afflicts humans and dogs. In order to map common aberrant genomic features...
5.
Giustina A, Barkan A, Beckers A, Biermasz N, Biller B, Boguszewski C, et al.
J Clin Endocrinol Metab
. 2019 Oct;
105(4).
PMID: 31606735
Objective: The aim of the Acromegaly Consensus Group was to revise and update the consensus on diagnosis and treatment of acromegaly comorbidities last published in 2013. Participants: The Consensus Group,...
6.
7.
Pujara S, Ioachimescu A
J Investig Med High Impact Case Rep
. 2017 Jun;
5(2):2324709617710040.
PMID: 28589154
Since the approval of sodium-glucose cotransporter 2 (SGLT2) inhibitors by the US Food and Drug Administration for type 2 diabetes, there have been several reports of euglycemic diabetic ketoacidosis in...
8.
Pappy 2nd A, Oyesiku N, Ioachimescu A
J Investig Med High Impact Case Rep
. 2016 Aug;
4(3):2324709616661834.
PMID: 27540557
We present the first case of iatrogenic hypothyroidism as a result of compounded thyroid hormone (T4/T3) therapy. The thyroid replacement was changed from 175 µg levothyroxine (LT4) to 57/13.5 µg...
9.
Hedley J, Law S, Phookan S, Lee M, Ioachimescu A, Levit R
J Investig Med High Impact Case Rep
. 2016 May;
4(2):2324709616646128.
PMID: 27152317
Diabetic ketoacidosis is a routinely encountered diagnosis in medicine. Physicians are trained early on to look for precipitants. Most clinicians assess for medication compliance, infection, ischemia, and the like. We...
10.
Anthony J, Esper G, Ioachimescu A
Pituitary
. 2015 Aug;
19(1):19-29.
PMID: 26267304
Purpose: Hypothalamic-pituitary (HP) neurosarcoidosis (NS) accounts for 0.5 % cases of sarcoidosis and 1 % of HP masses. Correlative data on endocrine and neurological outcomes is lacking. Methods: Retrospective case...